KMTS Kestra Medical Technologies Ltd.

I looked at the business behind $KMTS (KESTRA MEDICAL TECHNOLOGIES, LTD.) for you. Based on financial data and reported results. #KMTS

Kestra Medical Technologies reported fiscal Q1 2027 results after the market close, posting an adjusted loss of $0.75 per share for the quarter ended July 31, 2026, significantly worse than the $0.63 consensus estimate and wider than the $0.50 loss a year earlier. Revenue rose 60% year over year to $31.0 million, while gross margin expanded to 56.5% from 45.7%, and management raised its FY2027 revenue forecast to $141 million from $137 million, implying 48% growth from FY2026. However, GAAP net loss widened sharply to $44.1 million from $25.8 million, while adjusted EBITDA loss deepened to $24.0 million, raising concerns about the company’s path to profitability. Insider selling has also been heavily skewed, with 37 open-market sales versus just one purchase over the past six months. Short interest has climbed to nearly 11% of the public float, adding further downside pressure. $KMTS

$KMTS Q1 '27 Earnings Results & Recap • Reported GAAP EPS of -$0.75 down -50.00% YoY • Reported revenue of $30.97M up 59.89% YoY • Kestra Medical Technologies is increasing its FY27 revenue guidance to $141M, which represents growth of 48% compared to FY26, moving up from previous revenue guidance of $137M.

$KMTS prints AMC Mon — wearable defibrillator name. Fri's 22.44 low is my line into the print; lose that and I'm not chasing.

Anyone watching $KMTS into Monday AMC? Wearable defibrillator name (ASSURE WCD) prints after the close. Friday faded from a 24.38 high to a 22.81 close after tagging 22.44 — I'd want that low to hold into the print; slip through and the pre-earnings bid looks finished. Clean numbers reopen 23.91–24.38.